On 19 September 2017, the BMA patient liaison group hosted a symposium to discuss how the UK’s withdrawal from the EU will impact on health services and patient care.
The event explored the potential implications Brexit could have on: regulation of medicines and clinical trials, the treatment of visitors from the EU in the UK and vice versa, cross-border healthcare services in Ireland, research collaboration, public health and pan-EU networks tackling rare disease.
Breakout discussions in the morning and the afternoon provided chances for delegates to identify the key challenges and opportunities facing patients following Brexit.
Download the report
Watch videos from the event
Dr Paul Darragh What will be the impact of Brexit for patients in Northern Ireland?
Professor Tamara Harvey – will patients still be able to access healthcare in EU countries?
Professor Martin McKee – what does Brexit mean for cross-border health collaboration?